Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA007912 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA007912, RRID:AB_1844879
- Product name
- Anti-AGR2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human AGR2, Gene description: anterior gradient 2, Alternative Gene Names: AG2, HAG-2, PDIA17, XAG-2, Validated applications: WB, IHC, ICC, Uniprot ID: O95994, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references The Utility of SOX2 and AGR2 Biomarkers as Early Predictors of Tamoxifen Resistance in ER-Positive Breast Cancer Patients
Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
Itraconazole targets cell cycle heterogeneity in colorectal cancer
Duct- and Acinar-Derived Pancreatic Ductal Adenocarcinomas Show Distinct Tumor Progression and Marker Expression.
AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10‐mediated regulatory pathway
AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients
Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells
Zamzam Y, Abdelmonem Zamzam Y, Aboalsoud M, Harras H, Yip C
International Journal of Surgical Oncology 2021;2021
International Journal of Surgical Oncology 2021;2021
Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
Rodríguez-Blanco G, Zeneyedpour L, Duijvesz D, Hoogland A, Verhoef E, Kweldam C, Burgers P, Smitt P, Bangma C, Jenster G, van Leenders G, Dekker L, Luider T
Oncotarget 2018;9(92):36444-36456
Oncotarget 2018;9(92):36444-36456
Itraconazole targets cell cycle heterogeneity in colorectal cancer
Buczacki S, Popova S, Biggs E, Koukorava C, Buzzelli J, Vermeulen L, Hazelwood L, Francies H, Garnett M, Winton D
Journal of Experimental Medicine 2018;215(7):1891-1912
Journal of Experimental Medicine 2018;215(7):1891-1912
Duct- and Acinar-Derived Pancreatic Ductal Adenocarcinomas Show Distinct Tumor Progression and Marker Expression.
Ferreira RMM, Sancho R, Messal HA, Nye E, Spencer-Dene B, Stone RK, Stamp G, Rosewell I, Quaglia A, Behrens A
Cell reports 2017 Oct 24;21(4):966-978
Cell reports 2017 Oct 24;21(4):966-978
AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10‐mediated regulatory pathway
Hrstka R, Bouchalova P, Michalova E, Matoulkova E, Muller P, Coates P, Vojtesek B
Molecular Oncology 2015;10(5):652-662
Molecular Oncology 2015;10(5):652-662
AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients
Hrstka R, Brychtova V, Fabian P, Vojtesek B, Svoboda M
Disease Markers 2013;35
Disease Markers 2013;35
Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells
Stadler C, Rexhepaj E, Singan V, Murphy R, Pepperkok R, Uhlén M, Simpson J, Lundberg E
Nature Methods 2013;10(4):315-323
Nature Methods 2013;10(4):315-323
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human stomach and skeletal muscle tissues using HPA007912 antibody. Corresponding AGR2 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
